Tetra Radar · FDA Approvals · Decision date
bezuclastinib: FDA decision date
Cogent Biosciences, Inc. (COGT) · 30 November 2026
The FDA assigned a PDUFA target action date of November 30, 2026.
Source: 10-Q of 5 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.